What are spasticity treatment alternatives for patients with BoNT-A resistance?

Updated: Jun 28, 2019
  • Author: Krupa Pandey, MD; Chief Editor: Stephen A Berman, MD, PhD, MBA  more...
  • Print

A number of studies have confirmed that patients with BoNT-A resistance may benefit from injections with other serotypes such as botulinum toxin type B (BoNT-B). BoNT-B, which is now available commercially, and other serotypes, when they become available, may offer hope to patients with resistance to BoNT-A.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!